Divergent Trends for Two Leading Weight Loss Drugs! Strong Sales Ignite Eli Lilly's (LLY.US) Q2 Outperformance
智通财经2026/08/05 12:56Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
智通财经APP reported that Eli Lilly (LLY.US) announced second-quarter results before the market opened on Wednesday that exceeded market expectations, mainly due to strong sales of its injectable GLP-1 drug and its newly launched oral weight-loss drug Foundayo. As of press time, the company's shares are up 5%.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$80,345.83
-1.15%
Ethereum
ETH
$2,574.57
-2.53%
Tether USDt
USDT
$0.9996
-0.01%
BNB
BNB
$748.72
-2.28%
XRP
XRP
$1.38
-3.01%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$108.13
-3.32%
TRON
TRX
$0.3426
+1.52%
Zcash
ZEC
$1,437.58
-6.87%
Hyperliquid
HYPE
$90.94
-0.71%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now